Germana Falcone
Overview
Explore the profile of Germana Falcone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
461
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Izzo M, Battistini J, Golini E, Voellenkle C, Provenzano C, Orsini T, et al.
Clin Transl Med
. 2025 Feb;
15(2):e70227.
PMID: 39956955
Background: Myotonic dystrophy type 1 (DM1) is a genetic multisystemic disease, characterised by pleiotropic symptoms that exhibit notable variability in severity, nature and age of onset. The genetic cause of...
2.
Golini E, Rigamonti M, Raspa M, Scavizzi F, Falcone G, Gourdon G, et al.
Front Behav Neurosci
. 2023 Mar;
17:1130055.
PMID: 36935893
Myotonic dystrophy type 1 (DM1) is a dominantly inherited neuromuscular disease caused by the abnormal expansion of CTG-repeats in the 3'-untranslated region of the Dystrophia Myotonica Protein Kinase (DMPK) gene,...
3.
Cifola I, Fratini F, Cardinali B, Palmieri V, Gatti G, Selmi T, et al.
Biomedicines
. 2022 Aug;
10(8).
PMID: 36009432
Glioblastoma (GBM) is the most common and aggressive brain tumor in adults. Despite available therapeutic interventions, it is very difficult to treat, and a cure is not yet available. The...
4.
Izzo M, Battistini J, Provenzano C, Martelli F, Cardinali B, Falcone G
Int J Mol Sci
. 2022 May;
23(9).
PMID: 35563013
Myotonic dystrophy type 1 (DM1) is the most common muscular dystrophy affecting many different body tissues, predominantly skeletal and cardiac muscles and the central nervous system. The expansion of CTG...
5.
Cardinali B, Provenzano C, Izzo M, Voellenkle C, Battistini J, Strimpakos G, et al.
Mol Ther Nucleic Acids
. 2022 Jan;
27:184-199.
PMID: 34976437
CRISPR/Cas9-mediated therapeutic gene editing is a promising technology for durable treatment of incurable monogenic diseases such as myotonic dystrophies. Gene-editing approaches have been recently applied to and models of myotonic...
6.
Ondono R, Lirio A, Elvira C, Alvarez-Marimon E, Provenzano C, Cardinali B, et al.
Comput Struct Biotechnol J
. 2020 Dec;
19:51-61.
PMID: 33363709
Myotonic Dystrophy type 1 (DM1) is an incurable neuromuscular disorder caused by toxic DMPK transcripts that carry CUG repeat expansions in the 3' untranslated region (3'UTR). The intrinsic complexity and...
7.
Guglielmi L, Nardella M, Musa C, Cifola I, Porru M, Cardinali B, et al.
Cancers (Basel)
. 2020 Jun;
12(6).
PMID: 32575666
The identification of liquid biomarkers remains a major challenge to improve the diagnosis of melanoma patients with brain metastases. Circulating miRNAs packaged into tumor-secreted small extracellular vesicles (sEVs) contribute to...
8.
9.
Voellenkle C, Perfetti A, Carrara M, Fuschi P, Renna L, Longo M, et al.
Int J Mol Sci
. 2019 Apr;
20(8).
PMID: 31010208
Circular RNAs (circRNAs) constitute a recently re-discovered class of non-coding RNAs functioning as sponges for miRNAs and proteins, affecting RNA splicing and regulating transcription. CircRNAs are generated by "back-splicing", which...
10.
Greco S, Cardinali B, Falcone G, Martelli F
Int J Mol Sci
. 2018 Nov;
19(11).
PMID: 30400273
Circular RNAs (circRNAs) are a class of RNA produced during pre-mRNA splicing that are emerging as new members of the gene regulatory network. In addition to being spliced in a...